NCT00278031

Brief Summary

The aim of the study is to assess the quality of life of children who have been cured of retinoblastoma - a malignant eye tumor. The study is questionnaire-based, and uses standardized quality of life assessment tools.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
35

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Mar 2006

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 17, 2006

Completed
1 day until next milestone

First Posted

Study publicly available on registry

January 18, 2006

Completed
1 month until next milestone

Study Start

First participant enrolled

March 1, 2006

Completed
11.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2017

Completed
Last Updated

October 4, 2016

Status Verified

October 1, 2016

Enrollment Period

11.8 years

First QC Date

January 17, 2006

Last Update Submit

October 1, 2016

Conditions

Retinoblastoma

Keywords

RetinoblastomaQuality of life

Outcome Measures

Primary Outcomes (1)

  • Change in quality of life

    Baseline and 5 years

Eligibility Criteria

Age1 Year - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Long term survivors of childhood retinoblastoma

You may qualify if:

  • Past treatment for retinoblastoma

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hadassah Medical Organization, Jerusalem, Israel

Jerusalem, 91120, Israel

RECRUITING

MeSH Terms

Conditions

Retinoblastoma

Condition Hierarchy (Ancestors)

Neoplasms, NeuroepithelialNeuroectodermal TumorsNeoplasms, Germ Cell and EmbryonalNeoplasms by Histologic TypeNeoplasmsNeoplasms, Glandular and EpithelialNeoplasms, Nerve TissueRetinal NeoplasmsEye NeoplasmsNeoplasms by SiteEye Diseases, HereditaryEye DiseasesRetinal Diseases

Study Officials

  • Michael Weintraub, MD

    Hadassah Medical Organization

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Michael Weintraub, MD

CONTACT

972-2-6777408michaelw@hadassah.org.il

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
DIrector, Pediatric Hematology Oncology

Study Record Dates

First Submitted

January 17, 2006

First Posted

January 18, 2006

Study Start

March 1, 2006

Primary Completion

December 1, 2017

Study Completion

December 1, 2017

Last Updated

October 4, 2016

Record last verified: 2016-10

Data Sharing

IPD Sharing
Will share

Locations

IL(1)